Covidien's Almeida to add title of chairman

Covidien ($COV) President and CEO José Almeida has agreed to become chairman of the company's board of directors as of March 13. He replaces Richard Meelia, who has served as chairman since October 2008. Almeida's election comes roughly a month after the company announced plans to spin off its pharmaceuticals business into a stand-alone public company. The completion of the spinoff will take an estimated 18 months. Covidien release

Suggested Articles

Spinal Elements, maker of a wide range of implants and products for minimally invasive spine procedures, has filed a $100 million IPO.

United Airlines will begin providing COVID-19 screening tests for passengers, allowing those who test negative to skip local quarantine requirements.

Babson Diagnostics has closed its series A funding round with a total of $13.7 million and named a new CEO.